whole-genome sequencing
GeneDx Q1 Revenues Fall 20 Percent but Beat Consensus Estimate
Molecular diagnostic testing volume grew across all continuing operations in Q1 as GeneDx completed the shutdown of underperforming Sema4 assets.
Epic Sciences Raises $24M, Expands Commercial Infrastructure for Breast Cancer Liquid Biopsy Test
The firm is growing its sales, product marketing, and customer service teams for its multiomic metastatic breast cancer liquid biopsy test, DefineMBC.
Rolled out in partnership with Fabric Genomics, the test includes clinical WGS and variant analysis and interpretation services with a turnaround time of four weeks.
Illumina, Henry Ford Health Partner on Genomic Testing for Cardiovascular Patients
The partnership could yield data to support the use of whole-genome sequencing in treating and managing cardiovascular disease, the leading cause of death in the US.
Ultima Genomics, Genome Insight Partner on Low-Cost Whole-Genome Sequencing for Cancer Patients
Genome Insight will join Ultima's early-access program and optimize its whole-genome bioinformatics algorithm for cancer analysis using Ultima's technology.